Document ID: chunk:federal_register_of_legislation:F2024C00988:reg:103
Version: federal_register_of_legislation:F2024C00988
Segment Type: reg
Provision Reference: reg 103
Character Range: 168637–169789

103  Application provision relating to the National Health (Pharmaceutical Benefits) Amendment (2021 Measures No. 1) Regulations 2021
 (1) Sections 65A and 85A, as inserted by Part 1 of Schedule 1 to the National Health (Pharmaceutical Benefits) Amendment (2021 Measures No. 1) Regulations 2021, apply in relation to reduction days occurring on or after 1 July 2022.
 (2) The amendments made to section 84 by Part 2 of Schedule 1 to those Regulations apply to data collection periods beginning on or after 1 April 2022.
 (3) Section 73A, as inserted by Part 3 of Schedule 1 to those Regulations, and the amendments made to section 74 by Part 3 of Schedule 1 to those Regulations, apply to data collection periods beginning on or after 1 October 2022.
 (4) The amendments made to section 85 by Part 3 of Schedule 1 to those Regulations apply to information in relation to supplies of brands of pharmaceutical items occurring on or after 1 October 2022.
 (5) Sections 85B and 85C, as inserted by Part 4 of Schedule 1 to those Regulations, apply to information in relation to supplies of brands of pharmaceutical items occurring on or after 1 July 2023.